2024 POSTER PRESENTATIONS

P01: At-Home Blood Sample Collection: A New Avenue for Clinical Testing Using the Tasso+ Blood Collection Device, Presented by Elizabeth E., ARUP Laboratories

P02: Atomo Diagnostics - Implementing User-Centric Product Design to Improve Reliability and Performance of Blood-Based Rapid Testing, Presented by John K., Atomo Diagnostics Ltd.

P03: A Novel Hydrogel Particle Technology for Capture and Concentration of cfDNA, Presented by James E., Ceres Nanosciences

P04: Auto-Signal Enhancement for Lateral Flow Immunoassay, Presented by Sirowan R., Chulalongkorn University

P05: Quantum-Based Sensing of MicroRNA Biomarkers of Cancer Using NV-Center Nanodiamonds, Presented by Isaac R., Columbus Nanoworks

P06: From Concept to Clearance: The Future of AI / ML For Diagnostics, Presented by Surya S. & Srivaths K., Exponent, Inc.

P07: Microfluidic-Based, Isothermal Amplification and Quantification of Circulating Cell-Free DNA, Presented by Dmytro P., Fraunhofer Institute for Microengineering and Microsystems

P08: Quantification Method for Isothermal LAMP Amplification Diagnostics, Presented by Nathan B., Axxin

P09: Innovative FastAmp® Solution Enables Simple RPA-Based PoC Diagnostics and Nucleic Acids Testing of Viral Pathogens, Presented by Charles W., Intact Genomics, Inc.

P10: DNA Methylation in PBMCs: Advancing Liquid Biopsy for Early HCC Detection, Presented by David C., McGill University

P11: Supporting Translation of Novel Medical Devices through the NIH Blueprint MedTech Initiative, Presented by Yordan K., National Institutes of Health, National Institute on Drug Abuse

P12: Development of an Automated Workflow for Purification of Exosomes and Exosomal RNA, Presented by Eric V., Promega Corporation

P13: Seek Extraction™: Introducing a Rapid, Versatile, and Transformative Technology for Nucleic Acid Extraction, Presented by Deric H., Seek Labs

P14: Seek Amplification™: Introducing a Sensitive, Specific, and Equipment-Free DNA/RNA Amplification Technology to Revolutionize Molecular Diagnostic Testing for the Point of Care, Presented by Anindita R., Seek Labs

P15: Development and Validation of CRISPR-dCas9 Assay for Detection of SARS-CoV-2, Presented by Jee-Soo L., Seoul National University Hospital

P16: Polygenic Risk-Based Prediction of Chemotherapy-Associated Heart Failure, Presented by Tae-Min R., Seoul National University Hospital

P17: Reducing the Environmental Impact of Point-of-Care Diagnostics, Presented by Daniel G., TTP plc

P18: Platforms for Immunoassay at the Point-of-Care, Presented by Giles S., TTP plc

P19: The Challenge of Early-Stage Cancer Detection, Presented by Evgueni K., UCM Technologies, Inc.

P20: Single-CTC-Sensitive Low-Cost Liquid Biopsy Method Using Ultrasound Biomarker Release and qPCR, Presented by Roger Z., University of Alberta

P21: GigaFIBI; Rapid, Large-Format Histology-Resolution Imaging for Intraoperative Margins Assessment, Presented by Vimalatharmaiyah G., University of California, Davis

P22: Collagen and Elastin as Biomarkers for Studying Disease: Utilizing DUET Imaging, Presented by Willy J., University of California, Davis

P23: Rapid Point-of-Care Needle Biopsy Assessment, Enabled by FIBI (Fluorescence Imitating Brightfield Imaging), Presented by Dena S., University of California, Davis

P24: Identification of Novel Biomarkers for Anti-Toxoplasma gondii IgM Detection and Potential Application in Rapid Diagnostic Fluorescent Test, Presented by Hyun P., Wonkwang University

P25: Exploring Saliva as a Viable Liquid Biopsy Option for Cancer Biomarker Assays, Presented by Mark K., Wren Laboratories